Tue, January 3, 2012
Mon, January 2, 2012
Sat, December 31, 2011
Fri, December 30, 2011
Thu, December 29, 2011
Wed, December 28, 2011
Tue, December 27, 2011
Mon, December 26, 2011
Fri, December 23, 2011
Thu, December 22, 2011
Wed, December 21, 2011
Tue, December 20, 2011
Mon, December 19, 2011
Sun, December 18, 2011
Sat, December 17, 2011
Fri, December 16, 2011
Thu, December 15, 2011

Poniard Pharmaceuticals and Allozyne Terminate Planned Merger


//health-fitness.news-articles.net/content/2011/ .. icals-and-allozyne-terminate-planned-merger.html
Published in Health and Fitness on Thursday, December 22nd 2011 at 5:06 GMT by Market Wire   Print publication without navigation


December 22, 2011 08:00 ET

Poniard Pharmaceuticals and Allozyne Terminate Planned Merger

SAN FRANCISCO, CA--(Marketwire - Dec 22, 2011) - Poniard Pharmaceuticals, Inc. (NASDAQ: [ PARDD ]) today announced that Poniard and Allozyne, Inc. have mutually agreed to terminate the Agreement and Plan of Merger and Reorganization dated June 22, 2011. The termination follows the parties' determination that the common stock of the combined company resulting from the proposed merger will not qualify for listing on The Nasdaq Capital Market, which is a condition to closing of the merger. Poniard's board of directors is actively exploring alternatives for Poniard's business and assets.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products. For additional information please visit [ http://www.poniard.com ].



Publication Contributing Sources